BULLISHWHALES
BullishWhales · Analysts · Analyst Profile
BW Score Rank#255 of 347

Reni J. Benjamin

JMP Securities · Equity Research Analyst
ProvisionalRating since 2022No new ratings since Jun 2025

Analyst rating accuracy & track record

Reni J. Benjamin is an equity research analyst at JMP Securities. Bullish Whales has scored 39 of their stock calls across 13 companies. Their picks beat their sector 33% of the time over the next 12 months, and their price targets were reached 31% of the time within a year.

Win % vs sector
33%
PT Hit % (12mo)
31%
Avg sector-excess
−13.8%
Scored calls
39
Tickers
13
Tier
Provisional

Track record

Bullish Whales has scored 39 of Reni J. Benjamin's stock calls across 13 companies, dating back to 2022. Their rated stocks beat their own sector 33% of the time over the next 12 months. On a typical call, a Benjamin pick returned −13.8% more than its sector over the following year.

Of the scored calls, 39 were bullish (Buy). Most of their coverage sits in Financial Services. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
KURAKura Oncology Inc
Buy$28.00Jun 2025+17.2%Miss
SMMTSummit Therapeutics PLC
Buy$40.00Jun 2025−39.9%Miss
BCYCBicycle Therapeutics Ltd
Buy$22.00May 2025−52.1%Miss
PRLDPrelude Therapeutics Inc
Buy$4.00Apr 2025+341.4%Hit
KURAKura Oncology Inc
Buy$28.00Apr 2025+29.9%Miss
CUECue Biopharma
Buy$2.00Apr 2025−80.7%Miss
BCABBioatla Inc
Buy$1.00Mar 2025−58.5%Hit
SANASana Biotechnology Inc
Buy$5.00Mar 2025+31.8%Hit
ALLOAllogene Therapeutics Inc
Buy$5.00Mar 2025+27.2%Miss
PRLDPrelude Therapeutics Inc
Buy$4.00Mar 2025+370.5%Hit
SSSSSuRo Capital Corp
Buy$8.00Mar 2025+87.4%Hit
SKWDSkyward Specialty Insurance Group, Inc. Common Stock
Buy$60.00Mar 2025−12.7%Hit
BCYCBicycle Therapeutics Ltd
Buy$26.00Feb 2025−57.7%Miss
KURAKura Oncology Inc
Buy$28.00Feb 2025−19.1%Miss
STESTERIS plc
Buy$265.00Feb 2025+4.5%Hit
HOWLWerewolf Therapeutics Inc
Buy$4.00Jan 2025−72.2%Miss
BCYCBicycle Therapeutics Ltd
Buy$26.00Dec 2024−69.8%Miss
PRLDPrelude Therapeutics Inc
Buy$4.00Dec 2024+73.3%Hit
STROSutro Biopharma
Buy$17.00Dec 2024−66.3%Miss
PRLDPrelude Therapeutics Inc
Buy$7.00Sep 2024−42.1%Miss
BCABBioatla Inc
Buy$5.00Sep 2024−46.5%Miss
STROSutro Biopharma
Buy$17.00Sep 2024−67.3%Miss
CUECue Biopharma
Buy$2.00Jul 2024+35.1%Miss
HOWLWerewolf Therapeutics Inc
Buy$12.00Jun 2024−48.2%Miss
HOWLWerewolf Therapeutics Inc
Buy$12.00Jun 2024−56.4%Miss
BCABBioatla Inc
Buy$5.00May 2024−68.9%Miss
HOWLWerewolf Therapeutics Inc
Buy$12.00May 2024−79.5%Miss
HOWLWerewolf Therapeutics Inc
Buy$12.00Apr 2024−89.2%Miss
BCABBioatla Inc
Buy$12.00Mar 2024−89.3%Miss
PRLDPrelude Therapeutics Inc
Buy$7.00Mar 2024−84.3%Miss
SANASana Biotechnology Inc
Buy$15.00Mar 2024−78.3%Miss
BCABBioatla Inc
Buy$12.00Dec 2023+2.1%Miss
SANASana Biotechnology Inc
Buy$8.00Oct 2023−1.0%Hit
SANASana Biotechnology Inc
Buy$9.00Sep 2023−12.2%Hit
BCABBioatla Inc
Buy$12.00Aug 2023−57.3%Miss
CUECue Biopharma
Buy$15.00May 2023−75.4%Miss
BCABBioatla Inc
Buy$12.00May 2023−38.8%Miss
BCABBioatla Inc
Buy$12.00Mar 2023+11.5%Miss
BCABBioatla Inc
Buy$17.00Sep 2022−80.6%Miss
Go to

Reni J. Benjamin: analyst track record FAQ

Is Reni J. Benjamin a good stock analyst?

Yes, by track record. Reni J. Benjamin ranks number 255 of 347 of the analysts Bullish Whales scores, with a BW Score of 8 out of 100. Past results do not guarantee future ones.

What is Reni J. Benjamin's win rate?

Reni J. Benjamin's win rate is 33%. Across 39 scored calls, their rated stocks beat their sector 33% of the time over the next 12 months. On a typical call they returned −13.8% more than the sector.

What stocks and sectors does Reni J. Benjamin cover?

Reni J. Benjamin covers 13 companies, with the most coverage in Financial Services. See the ratings table above for every scored call and its outcome.

Are Reni J. Benjamin's price targets accurate?

Reni J. Benjamin's price targets are reached within 12 months 31% of the time. The base rate across all analysts Bullish Whales tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Bullish Whales scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Reni J. Benjamin's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Bullish Whales score analyst accuracy?

Bullish Whales scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Reni J. Benjamin rank among Wall Street analysts?

Reni J. Benjamin ranks number 255 of 347 by BW Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30